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Gaps in the HIV care continuum contribute to poor health outcomes and increase HIV trans-
mission. A combination of interventions targeting multiple steps in the continuum is needed
to achieve the full beneficial impact of HIV treatment.
Methods and findings
Link4Health, a cluster-randomized controlled trial, evaluated the effectiveness of a combina-
tion intervention strategy (CIS) versus the standard of care (SOC) on the primary outcome
of linkage to care within 1 month plus retention in care at 12 months after HIV-positive test-
ing. Ten clusters of HIV clinics in Swaziland were randomized 1:1 to CIS versus SOC. The
CIS included point-of-care CD4+ testing at the time of an HIV-positive test, accelerated anti-
retroviral therapy (ART) initiation for treatment-eligible participants, mobile phone appoint-
ment reminders, health educational packages, and noncash financial incentives. Secondary
outcomes included each component of the primary outcome, mean time to linkage, assess-
ment for ART eligibility, ART initiation and time to ART initiation, viral suppression defined
as HIV-1 RNA < 1,000 copies/mL at 12 months after HIV testing among patients on ART6
months, and loss to follow-up and death at 12 months after HIV testing. A total of 2,197
adults aged18 years, newly tested HIV positive, were enrolled from 19 August 2013 to 21
November 2014 (1,096 CIS arm; 1,101 SOC arm) and followed for 12 months. The median
participant age was 31 years (IQR 26–39), and 59% were women. In an intention-to-treat
analysis, 64% (705/1,096) of participants at the CIS sites achieved the primary outcome ver-
sus 43% (477/1,101) at the SOC sites (adjusted relative risk [RR] 1.52, 95% CI 1.19–1.96,
p = 0.002). Participants in the CIS arm versus the SOC arm had the following secondary
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outcomes: linkage to care regardless of retention at 12 months (RR 1.08, 95% CI 0.97–
1.21, p = 0.13), mean time to linkage (2.5 days versus 7.5 days, p = 0.189), retention in care
at 12 months regardless of time to linkage (RR 1.48, 95% CI 1.18–1.86, p = 0.002), assess-
ment for ART eligibility (RR 1.20, 95% CI 1.07–1.34, p = 0.004), ART initiation (RR 1.16,
95% CI 0.96–1.40, p = 0.12), mean time to ART initiation from time of HIV testing (7 days
versus 14 days, p < 0.001), viral suppression among those on ART for6 months (RR 0.97,
95% CI 0.88–1.07, p = 0.55), loss to follow-up at 12 months after HIV testing (RR 0.56, 95%
CI 0.40–0.79, p = 0.002), and death (N = 78) within 12 months of HIV testing (RR 0.80, 95%
CI 0.46–1.35, p = 0.41). Limitations of this study include a small number of clusters and the
inability to evaluate the incremental effectiveness of individual components of the combina-
tion strategy.
Conclusions
A combination strategy inclusive of 5 evidence-based interventions aimed at multiple steps
in the HIV care continuum was associated with significant increase in linkage to care plus





Why was this study done?
• Linkage to care, retention in care, and achievement of viral load suppression on antire-
troviral therapy (ART) among HIV-positive adults are necessary in order to achieve
optimal health outcomes in terms of reduced morbidity and mortality and to decrease
the risk of HIV transmission to others.
• Barriers to linkage to and retention in care are multifactorial and include both individ-
ual- and health system-level factors.
• We hypothesized that a multicomponent strategy using a combination of evidence-
based interventions was needed to address the multiple gaps in linkage to and retention
in care across the HIV care continuum.
What did the researchers do and find?
• Ten clusters of affiliated HIV clinics in Swaziland were randomized to receive the stan-
dard of care (SOC; 1,101 participants) or a combination intervention strategy (CIS;
1,096 participants). The CIS included provision of participants with point-of-care CD4
+ count testing at time of HIV testing, accelerated ART initiation among eligible
patients, mobile phone appointment reminders, health educational packages, and non-
cash financial incentives.
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• Participants were followed for 12 months from the time of testing HIV positive, and the
primary study outcome was prompt linkage to care within 1 month of testing HIV-posi-
tive plus retention in care at 12 months after testing HIV positive. Secondary outcomes
included additional steps in the HIV care continuum.
• We found that participants receiving care at HIV clinics randomized to the CIS study
arm, as compared to the SOC study arm, were significantly more likely to achieve the
primary outcome of prompt linkage to care plus 12-month retention (64% in the CIS
arm versus 43% in the SOC arm, relative risk [RR] 1.52, 95% CI 1.19–1.96, p = 0.002).
• We also found that participants at CIS sites versus SOC sites had faster linkage to care,
were more likely to be assessed for ART initiation, and had faster time to ART start.
However, we did not find significant differences in viral suppression or mortality at 12-
months after testing HIV positive.
What do these findings mean?
• The Link4Health study showed that a CIS was 50% more effective than the SOC on
prompt linkage to HIV care plus 12-month retention after HIV-testing and that the
effect appeared to be primarily driven by enhanced retention in care.
• Limitations of this study include a small number of clusters and the inability to evaluate
the contribution of each of the components of the strategy to the effect noted.
• The combination strategy used in this study could be easily adapted to other resource-
limited settings and may be relevant to the challenges faced in engaging HIV-positive
vulnerable and key populations.
Introduction
Achieving the desired impact of HIV treatment, as measured by individual health outcomes
and reduced transmission to others, is contingent upon completing all steps in the HIV care
continuum, from identifying all individuals who are living with HIV and linking those found
to be HIV positive to HIV care to retaining them in lifelong care and on antiretroviral therapy
(ART) [1]. Over the past decade, the scale-up of HIV programs has been substantial, with over
18 million persons having initiated ART by the end of 2015 in low- and middle-income coun-
tries and an associated substantial decrease in HIV-related morbidity and mortality, as well as
evidence of a decrease in HIV incidence in many of the most severely affected countries [2].
However, in order to achieve epidemic control, further optimization of the HIV care contin-
uum is needed so as to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)
90/90/90 targets, which require that 90% of individuals with HIV are aware of their diagnosis,
that 90% of those aware of their HIV infection are initiated on ART, and that 90% of those on
treatment achieve and maintain viral suppression [3].
Findings from HIV programs indicate that linkage to and retention in HIV care currently
fall far short of the desired goals [4–6]. Linkage of HIV-positive individuals to HIV care varies
from less than half of individuals linking to care within 6 months of an HIV-positive test to
72% who ever linked [5,7,8]. Once linked to care, less than half of HIV-positive patients are
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retained in care prior to initiation of ART, with only two-thirds of ART-eligible individuals
initiating ART [5,7]. Lastly, only approximately three-quarters of patients initiated on ART
have been noted to be retained in care at 12 months, with retention decreasing over the ensu-
ing follow-up years [4].
Barriers to linkage to and retention in care are multifactorial and include both individual-
and health system-level factors such as stigma, fear of disclosure, distance and cost of travel to
clinic, attitudes of providers, and cumbersome clinic procedures with long waiting times
[9,10]. Previous studies that aimed to overcome such barriers have largely focused on the
assessment of 1 intervention primarily targeting a single step in the HIV care continuum [11–
14]. We postulated that in order to address the multiple gaps across the care continuum, a
multi-component intervention strategy is needed, with each component targeting one or more
steps in the HIV care continuum.
The Link4Health study evaluated the effectiveness of a combination intervention strategy
(CIS) utilizing 5 evidence-based interventions that address structural, behavioral, and biomed-
ical barriers across the continuum of care, to improve linkage to and retention in care among
newly identified HIV-positive adults in Swaziland.
Methods
Ethics
The study was approved by the institutional review boards at Columbia University and the
Swaziland Scientific and Ethics Committee.
Study design
A detailed description of the study methods was previously reported [15]. In brief, Lin-
k4Health was an implementation science study using a cluster site-randomized trial design.
The study unit of randomization consisted of a public secondary-level HIV clinic paired with
its largest affiliated public primary-level HIV clinic. Ten study units were selected from a total
of 11 existing secondary-level HIV clinics in the country, based on clinic patient volume.
Study units were pair matched, first by implementing partner (matching the 2 study units
from implementing partner A) and then by location (urban [4] versus rural [4]) and clinic
size, based on the estimated number of adults testing HIV positive in the 2 years prior to study
implementation (<50 versus >50 per month for rural study units and <100 versus >100 per
month for urban study units). Matched study units were randomized by a computerized ran-
dom number generator to the CIS or standard of care (SOC) study arm. A cluster design was
chosen to avoid disruption of service delivery, enable better fit within the routine workings at
the clinical site, and allow the clinic staff to more easily implement the study. The study staff
and clinic providers at each study unit were not blinded to the assigned arm for the site.
Study setting and population
Swaziland is located in Southern Africa and has the world’s highest HIV prevalence, with HIV
as the leading cause of death in the country [16]. The estimated adult (age 18–49 years) HIV
prevalence is 31%, and the estimated incidence is 2.4% (95% CI 2.1–2.8) [17, 18]. The country
has made impressive strides in responding to the epidemic, with nearly 70% of persons esti-
mated to be living with HIV having initiated ART as of 2015 [19]. Nevertheless, historic rates
of linkage to and retention in care at 12 months after ART initiation remain suboptimal [20].
Data available from Swaziland at the time of the initiation of the study showed that among
1,105 adults who tested HIV positive at community testing venues, only 37% linked to HIV
Link4Health: A combination intervention to improve HIV care
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002420 November 7, 2017 4 / 20
care within 12 months of HIV testing [21]. Retention among adults at 36 months after ART
start was 68% in 2011 per national estimates [22].
Inclusion criteria were as follows: adults aged18 years, newly tested HIV positive, and
willing to receive HIV care at the study unit and consent to study procedures. Exclusion crite-
ria were as follows: planning on leaving the community during the study, prior enrollment in
HIV care or initiation of ART in the past 6 months, currently on ART, reports a current preg-
nancy, or not able to speak English or SiSwati.
Study interventions
All adults who tested HIV positive at participating sites were informed of the study by their
providers. Interested individuals were referred to a study nurse who provided further informa-
tion, confirmed eligibility, and, if eligible, obtained written consent. All consenting partici-
pants provided baseline information and thereafter were managed based on the study arm to
which the clinic was randomly assigned.
SOC
Participants at study units randomized to the SOC arm were managed according to country
guidelines. These guidelines recommend that individuals identified as HIV positive receive
post-test counseling and be referred to an HIV clinic using a national referral form [21].
Thereafter, upon presentation at their first HIV clinic visit, such individuals are to present
their referral form, receive a clinical assessment, and have blood drawn for a CD4+ count test
as well as hematology and chemistry tests and are instructed to return in 1–2 weeks for receipt
of their results. Upon return, those eligible for ART according to then prevailing national
guidelines (i.e., with a CD4+ count 350 cells/mm3) are to receive the first of 3 counseling
sessions. Patients who are prescribed ART are instructed to return to the clinic every month
for 6 months and then every 3 months, if they are stable on treatment. Patients who are ineligi-
ble for ART are instructed to return to clinic every 3 months for follow-up. Peer counselors
are encouraged to call patients within 7 days of a missed clinic appointment. All patients are
prescribed cotrimoxazole prophylaxis, and condoms, and health informational materials are to
be made available in the clinics.
CIS
Participants at clinics randomized to the CIS arm received a multicomponent strategy of 5 evi-
dence-based interventions, targeting structural, biomedical, and behavioral barriers, which are
described briefly below (Table 1) [15]. All components of the combination strategy utilized in
this study were selected based on evidence of their effectiveness, feasibility, and suitability to
patients in diverse healthcare settings.
The first intervention was provision of point-of-care (POC) CD4+ count testing performed
immediately after an HIV-positive test, in the same physical location as the HIV testing site,
with the aim of improving linkage to care, assessment for ART eligibility, and prompt ART ini-
tiation. Several studies have reported higher linkage and ART initiation rates with POC CD4+
count testing as compared to traditional CD4+ count testing [23–26].
The second intervention of accelerated ART initiation for eligible patients (CD4+ count
350 cells/mm3 or WHO stage III/IV) involved 2 rather than 3 counseling sessions and recom-
mended ART initiation within the first week after linkage to care. Delays in ART initiation
among those eligible for treatment have been shown to be associated with increased morbidity
and mortality [27]. Late ART initiation is also associated with a longer period of increased
infectiousness due to ongoing viral replication [28]. In this study, initiation of ART promptly
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rather than waiting for the return of baseline safety laboratory test results was strongly encour-
aged, and a checklist was made available to the providers to assist in identifying those potential
participants at risk for renal insufficiency who would require waiting for the serum creatinine
results prior to ART initiation.
The third intervention involved use of short-message-service (SMS) appointment remind-
ers, sent from a central server, which aimed at improving linkage to and retention in care
among participants. SMS reminders were sent 3 days prior to an appointment and after a
missed appointment. The message did not contain any information relating to HIV status.
SMS communications have been used in HIV care and other chronic disease management to
improve health communication and patient adherence [29–37].
The fourth intervention was a health education package that included health information
and supplies such as soap, a toothbrush, and a pill box, which also aimed to improve both link-
age to and retention in care. A package of different materials and information was given every
3 months. A similar intervention has been evaluated in Uganda and was associated with high
rates of cotrimoxazole use, condom use, and HIV testing of family members [38].
Lastly, financial incentives of modest amount were provided that served to reimburse par-
ticipants for expenses or lost wages or transport costs for clinic attendance [39]. This interven-
tion was selected because there has been great interest in the use of financial incentives as a
structural intervention to achieve positive health behaviors including retention in care [39–
45]. A noncash type of financial incentive was provided in the form of a prepaid mobile phone
Table 1. Comparison of combination intervention strategy (CIS) to standard of care (SOC) procedures.
Intervention Standard of care (SOC) Combination intervention strategy (CIS) Type of
intervention





• Point-of-care CD4 assays available in some
primary care clinics and some secondary
health centers/hospitals for patients enrolled
in HIV care but not at the HIV testing site
• CD4+ count (Cyflow and FACS Caliber)
after linkage to HIV care in the clinic or lab
• Turnaround time approximately 2 weeks
• Point-of-care CD4 assays at the HIV
testing site at the time of HIV testing








ART initiation per national guidelines for
patients with CD4+ count 350 cells/mm3 or
WHO Stage III/VI
• Requires 3 counseling sessions and receipt
of baseline lab tests
• Initiation 2 weeks to 1 month from
determination of ART eligibility
• Accelerated ART initiation for patients with
point-of-care CD4+ count 350 cells/mm3
within 1 week from testing
• Two counseling sessions (1 at the time of
HIV testing and the other at the first HIV
clinic visit) and collection of blood for other
baseline lab tests
• Initiation of ART for eligible patients prior to







• Telephone call within 7 days of missed visit
for ART patients only
• SMS (or voice if illiterate) visit reminders 3
days prior to each scheduled visit
• SMS (or voice if illiterate) reminder within 7
days after a missed visit for all patients




• Cotrimoxazole was prescribed for all
patients once enrolled in HIV care
• Condoms available
• A health education package was provided
approximately every 3 months at visits.
Packages included condoms, soap,
cotrimoxazole, a pill box, and pictorial







• None • Noncash financial incentive (mobile
airtime) were provided for those linked to
care within 1 month of testing and
completion of 6- and 12-month visits
Structural Linkage and retention
Abbreviations: ART, antiretroviral therapy; SMS, short message service.
https://doi.org/10.1371/journal.pmed.1002420.t001
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card valued at US$8 and was given to participants upon linkage to care within 1 month of HIV
testing and at completion of 6 and 12 months in follow-up care.
Data collection and study measures
All participants completed a baseline questionnaire, at the time of study enrollment, which
solicited information on sociodemographic characteristics, HIV disease history, barriers to
care, travel time to clinic, depression, social and family support, and HIV-related knowledge.
Follow-up questionnaires were conducted at 1 and 12 months after enrollment, at the partici-
pant’s home or a prespecified location in the community, to collect information on changes in
sociodemographic characteristics, self-reported linkage to care and retention, preferences
about the study interventions, and vital status, if the latter was not known. Clinical data includ-
ing CD4+ count, WHO Stage, date of ART initiation, ART regimen, and clinic and pharmacy
visit dates were abstracted from participants’ medical charts—the data source for the primary
outcome. These data were collected between 3–6 months after the participant reached the end
of the study follow-up period. If the participant’s medical record was missing, he/she was
assumed to have not achieved the primary outcome. Death was ascertained via medical record
reviews or at the time of the 1- or 12-month interview. Viral load measurement was done
using dried blood samples (DBSs) (HIV-1 RNA Abbott m2000rt system) collected at the time
of the 12-month questionnaire at the participant’s home or a prespecified location [46].
Study outcomes
The primary outcome was a combined outcome of linkage to HIV care within 1 month of HIV
testing plus retention in care at 12 months from HIV testing among participants at the individual
level. Linkage to care was defined by participant attendance of at least 1 visit to an HIV clinic with
completion of an intake assessment including medical history and physical exam. Retention in
care at 12 months after HIV testing was defined as no documented death and a clinic visit at the
study unit within 90 days prior to the end of the study follow-up period. Participants with a miss-
ing medical record at the time of medical record abstraction were considered nonretained.
Secondary endpoints included evaluation of the effectiveness of the CIS compared to the SOC
with regard to the following: each component of the primary outcome described above, time to
linkage, ART eligibility, ART initiation, time to ART initiation, viral suppression defined as HIV-
1 RNA< 1,000 copies/mL at 12 months among patients on ART for at least 6 months, and death
and loss to follow-up at 12 months after HIV testing. Death and transfer status were ascertained
from medical records and through the 12-month follow-up visit questionnaire. Linkage and
retention at clinics other than the assigned study unit were assessed in a sensitivity analysis using
self-reported linkage and retention data from the 1- and 12-month questionnaires.
Statistical analysis
The study sample size was calculated by estimating that 35% of the participants in the SOC
study arm would achieve the primary outcome (assuming that 50% link to HIV care within 1
month of testing and that 70% of those linking within 1 month are retained at 12 months after
testing). We estimated that approximately 2,750 adults would be eligible for study enrollment
based on historic HIV testing volume and the proportion of individuals testing HIV positive at
the study units in the year prior to the study start. Assuming 80% of eligible individuals would
consent to enrollment, we estimated an average enrollment of 220 participants per study unit
or 2,200 in total (1,110 per study arm). With this sample size and 5 study units per study arm,
we then estimated the minimum difference in the primary outcome we could detect with 80%
power, 2-sided alpha of 0.05, assuming an interclass correlation coefficient (ICC) of 0.05. In a
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post hoc analysis, we estimated the ICC of the primary outcome using the method outlined by
Snijders and Bosker for binary outcome data [47].
An intent-to-treat analysis compared the relative risk (RR) of achieving the primary out-
come between study arms, with each having 5 clusters per arm. Within study unit clustering
was accounted for using random-intercept multilevel models. For dichotomous outcomes,
log-Poisson models with robust standard error were used. For continuous outcomes, random-
intercept linear regression models were used. Assessment of potential confounding despite
cluster randomization was performed by constructing multivariable random-intercept regres-
sion models including covariates found statistically different between treatment arms at an
alpha of 0.01. Additionally, we conducted a per-protocol analysis comparing the RR of achiev-
ing the primary outcome among participants who received the full package of the CIS for the
duration of study participation. Sensitivity analysis assessed any changes to the intent-to-treat
analysis after including self-reported linkage and retention obtained from follow-up surveys.
In post hoc analyses, assessment of the RR for achieving the primary outcome by key sub-
groups was done using interaction contrast ratios.
Results
Study population
Of the 10 study units included in this study, 6 were located in urban areas, and 4 in rural areas.
At study units randomized to the CIS study arm, a total of 1,234 individuals were screened for
eligibility, with 1,096 (89%) enrolled in the study from 19 August 2013 to 21 November 2014
(Fig 1). At study units assigned to the SOC study arm, a total of 1,316 were screened, with
1,101 (84%) enrolled. Study refusal differed by study arm, with 23 refusals (1.9%) in the CIS
arm and 114 refusals (8.7%) in the SOC arm (p< 0.001). Reasons for ineligibility are shown in
Fig 1, with 111 participants ineligible in the CIS arm compared to 101 in the SOC arm.
Among 2,197 participants included in this analysis, 1,294 (59%) were female, and the
median age was 31 years (IQR 26–39), with 445 (20%) of the participants being young adults
aged 18–24 years (Table 2). Forty-five percent reported no education or only primary school-
ing; approximately half were unemployed. Median individual weekly income was US$9 (IQR
US$0–US$37). Eighty-four percent reported living in the current residence for more than 1
year, with 16% reporting travel away from home for over a 1-month duration in the past year.
The median travel time from residence to HIV clinic was 30 minutes (IQR 20–50). The major-
ity (80%) were diagnosed with HIV through a voluntary counseling and testing site, with the
remainder having received HIV testing through provider-initiated testing and counseling at
clinics within the study units. Over half (54%) of the participants reported that this was their
first HIV test, while 89% indicated that it was their first positive HIV test.
Primary outcome
In the intent-to-treat analysis, 705 (64%) participants at sites randomized to the CIS study arm
and 477 (43%) participants at sites randomized to the SOC study arm achieved the primary
outcome of linkage to HIV care within 1 month of HIV-positive testing plus retention in HIV
care at 12 months after HIV testing, for an RR of 1.48 (95% CI 1.37–1.61, p< 0.001). Account-
ing for clustering within study units, the RR was 1.52 (95% CI 1.19–1.96, p = 0.002) (Fig 2,
Table 3). Additionally, adjusting for covariates significant in the bivariate analyses listed in
Table 2 did not appreciably change the results. A total of 64 (6%) of participants in the CIS
arm and 144 (13%) of participants in the SOC arm did not have a medical record and were
classified as “not linked” to HIV care.
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The RR in the per-protocol analysis accounting for clustering for achieving the primary
outcome was 1.68 (95% CI 1.32–2.15, p = 0.003) (Table 3). The RR in the sensitivity analysis,
accounting for clustering, which included participants who self-reported linkage and retention
in the 1- and 12-month surveys at a clinic other than 1 with their assigned study unit, was 1.41
(95% CI 1.13–1.74, p = 0.004), respectively (Table 3). Using this approach, we calculated an
ICC of 0.086, similar to but slightly higher than the assumed ICC used in power and sample
size estimation.
The CIS strategy was delivered according to the study protocol to 937 (85%) of the 1,096
participants enrolled in study units assigned to the CIS. Reasons for not receiving all of the CIS
strategy intervention components included missing POC CD4+ count testing (<1% CIS par-
ticipants), missing an ART counseling session per accelerated ART procedures (3%), missing
receipt of 1 healthcare bag (2%), and missing receipt of 1 financial incentive (9%). There was
heterogeneity in the primary outcome across the 5 pairs of matched study units. The propor-
tion of participants who achieved the primary outcome in study units randomized to the CIS
ranged from 49% to 82%, while this ranged from 22% to 57% in the study units randomized to
SOC.
Fig 1. Flow diagram of study enrollment. ART, antiretroviral therapy; CIS, combination intervention strategy; SOC, standard of care; SU, study unit.
https://doi.org/10.1371/journal.pmed.1002420.g001
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Secondary outcomes
A similar proportion of participants linked to care anytime during the study follow-up period
in both study arms: 1,032 (94%) in the CIS arm as compared to 957 (87%) in the SOC arm (RR
1.08, 95% CI 0.97–1.21, p = 0.13), with no significant differences in linkage within the same
Table 2. Participant characteristics at HIV testing (N = 2,197).
Characteristics CIS arm SOC arm Total
N % N % N %
1,096 1,101 2,197
Female 657 60% 637 58% 1,294 59%
Age (years) Median (IQR) 32 (26–40) 30 (25–39) 31 (26–39)
18–24 210 19% 235 21% 445 20%
25–39 612 56% 604 55% 1,216 55%
40–49 158 14% 166 15% 324 15%
>50 116 11% 95 9% 211 10%
Missing/refused 1 0% 1 0%
Education None/primary 478 44% 519 47% 997 45%
Secondary or higher 617 56% 581 53% 1,198 55%
Missing/refused 1 0% 1 0% 2 0%
Weekly income Median (IQR) US$9 (US$0-US$37) US$14 (US$0-US$37) US$9 (US$0-US$37)
Unemployed 624 57% 531 48% 1,155 53%
Married 400 36% 408 37% 808 37%
Number of living children 0 206 19% 207 19% 413 19%
1 to 3 645 59% 680 62% 1,325 60%
>3 243 22% 214 19% 457 21%
Missing/refused 2 0% 0 0% 2 0%
Lives alone 116 11% 160 15% 276 13%
Away from home >1 month in past year 179 16% 170 15% 349 16%
Time at current residence 1 year or less 164 15% 192 17% 356 16%
Greater than 1 year 930 85% 906 82% 1,836 84%
Missing/refused 2 0% 3 0% 5 0%
Travel time to clinic Median (IQR) time minutes 30 (20–45) 30 (20–60) 30 (20–50)
<30 minutes 690 63% 584 53% 1,274 58%
31–60 minutes 330 30% 323 29% 653 30%
>60 minutes 62 6% 191 17% 253 11%
Missing/refused 14 1% 3 0% 17 1%
Currently on TB treatment 8 1% 14 1% 22 1%
HIV testing site VCT 937 85% 820 74% 1,757 80%
PITC 159 15% 280 25% 439 20%
Missing/refused 0 0% 1 0% 1 0%
First HIV test 642 59% 539 49% 1,181 54%
First positive HIV test 967 88% 978 89% 1,945 89%
Household member with HIV 427 39% 348 32% 775 35%
Alcohol consumption in the last 7 days Every day 16 1% 18 2% 34 2%
Some days 235 21% 234 21% 469 21%
Never 845 77% 849 77% 1,694 77%
Abbreviations: CIS, combination intervention strategy; PITC, provider-initiated testing and counselling; SOC, standard of care; TB, tuberculosis; VCT,
voluntary HIV counselling and testing.
https://doi.org/10.1371/journal.pmed.1002420.t002
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day or 1 month after testing (Table 3). The mean time to linkage to care was shorter in the CIS
arm versus the SOC study arm but was not statistically different (2.5 compared to 7.5 days,
p = 0.189). However, among those who ever linked to care (1,032 in the CIS study arm and 957
in the SOC study arm), significantly fewer patients (13%) in CIS sites versus SOC sites (18%)
did not return for subsequent visits after the first clinic visit (p = 0.008).
Assessment for ART eligibility through either a CD4+ count or WHO staging was done for
all participants in the CIS arm as compared to 84% of participants in the SOC arm (RR 1.20,
95% CI 1.07–1.34, p = 0.004). The mean time to ART eligibility assessment was 0 days in the
CIS study arm compared to 6.3 days in the SOC arm (p< 0.001). The median CD4+ count
among 1,096 participants in the CIS arm who had POC CD4+ count testing done at the time
of HIV testing was 311 cells/mm3 (IQR 159–443). Among the 907 (82%) participants in the
SOC arm who linked to HIV care and had a CD4+ count done, the median CD4 count was
285 cells/mm3 (155–444) (p = 0.07).
Fig 2. Proportion of participants who achieved the primary outcome of linkage to HIV care within 1 month of HIV testing plus retention in HIV
care at 12 months after HIV testing by study arm (combination intervention strategy [CIS] and standard of care [SOC]).
https://doi.org/10.1371/journal.pmed.1002420.g002
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Table 3. Primary and secondary outcomes for the combination intervention strategy (CIS) and standard of care (SOC) study arms.
CIS group (N = 1,096) SOC group (N = 1,101) Relative risk (RR)
N % N % RR 95% CI p-Value
Primary outcome Intention to treat 705 64% 477 43% 1.48 (1.37–1.61) <0.001
Intention to treat accounting for
clustering1
705 64% 477 43% 1.52 (1.19–1.96) 0.002
Intention to treat accounting for
clustering and differences in
covariates1,3
705 64% 477 43% 1.50 (1.12–1.99) 0.009
Per protocol1,2 672 69% 447 43% 1.68 (1.32–2.15) <0.001
Sensitivity analysis1,4 761 69% 557 51% 1.41 (1.13–1.74) 0.004
Secondary outcomes
Linkage Linked to care (ever)1 1032 94% 957 87% 1.08 (0.97–1.21) 0.13
Mean (SD) time from HIV testing to
linkage
2.5 days (19.5) 7.5 days (46.6) 0.189
ART eligibility Assessed for ART eligibility1 1,096 100% 920 84% 1.20 (1.07–1.34) 0.004
Became ART eligible1 833 76% 721 65% 1.18 (1.01–1.37) 0.038
Mean (SD) time from HIV testing to ART
eligibility assessment5
0 (0) 6.3 (35.5) <0.001
ART initiation* Initiated ART (ever)1* 710 65% 635 58% 1.16 (0.96–1.40) 0.12
Median (IQR) time from testing HIV
positive to ART initiation among ART
eligible, days6
7.0 (3.0–21.0) 14.0 (7.0–31.0) <0.001
Retention regardless of time
to linkage and ART status
Retained 12 months after HIV testing1 720 66% 498 45% 1.48 (1.18–1.86) 0.002
Viral suppression Viral suppression (HIV-1 RNA < 1,000
copies/ml) among participants on ART
for6 months (N = 477 CIS and
N = 451 SOC)1,7
419 88% 406 90% 0.97 (0.88–1.07) 0.55
Deaths within 12 months of
HIV testing
Total deaths1 35 3% 43 4% 0.80 (0.46–1.35) 0.41
Death before ART initiation1 10 1% 23 2% 0.44 (0.19–1.01) 0.05
Death after ART initiation1 25 2% 20 2% 1.18 (0.57–2.47) 0.63
Transfers within 12 months of
HIV testing
Total transfers1 23 2% 26 2% 0.88 (0.44–1.77) 0.71
Transfers before ART initiation1 7 1% 19 2% 0.37 (0.16–0.85) 0.02
Transfers after ART initiation1 16 1% 7 1% 2.10 (0.72–6.18) 0.16
Lost to follow-up within 12
months of HIV testing
Total lost to follow-up1 318 29% 534 49% 0.56 (0.40–0.79) 0.002
Lost to follow-up before ART initiation1 240 22% 357 32% 0.60 (0.40–0.89) 0.014
Lost to follow-up after ART initiation1 78 7% 177 16% 0.51 (0.31–0.85) 0.013
1 Accounting for within-study unit clustering using random intercept log-Poisson regression models with robust standard error.
2 The per-protocol analysis compared all patients in the SOC arm to those in the CIS arm self-reporting receipt of all interventions: point-of-care (POC) CD4
+ count, accelerated antiretroviral therapy (ART) initiation (if eligible), health education package, short message service (SMS), and financial incentives. A
total of 937 of the 1,096 patients in the CIS arm were included. Patients were excluded for the following: missing PIMA (2), ART counseling session #1 (24),
ART counseling session #2 (14), first health education package (7), second health education package (12), third health education package (4), fourth health
education package (2), financial incentive for linkage to care (86), second financial incentive (8), or third financial incentive (4).
3 Additionally adjusting for covariates significantly different between groups at an alpha of 0.1: employment status, number of children, whether the
participant lives alone, HIV testing location, family member with HIV, travel time to clinic, and whether this was the participant’s first HIV test.
4 The sensitivity analysis considers participants linked to HIV care or retained in HIV care if they are recorded as linked and retained in their medical records
or if they self-reported linkage or retention in the 1- and/or 12-month study questionnaire.
5 All participants in the SOC arm were assessed for ART eligibility at the time of testing HIV positive. Of the SOC participants, 920/1,101 (84%) were
assessed at enrollment into HIV care or clinical follow-up.
6 Time to ART initiation measured from date of HIV-positive test to ART initiation among those becoming ART eligible. The p-values are Wilcoxon tests of
differences between medians.
7 The proportion of viral load suppression (<1,000 copies/ml) among participants who were on ART for6 months with available viral loads is reported in the
table. Among all participants who were on ART for6 months, 85% (419/493) in the CIS arm and 89% (406/458) in the SOC arm had viral suppression.
* In the CIS arm, 85% of those ART eligible initiated ART. In the SOC arm, 88% of those eligible initiated ART.
https://doi.org/10.1371/journal.pmed.1002420.t003
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A total of 710 participants (85% of ART-eligible participants) in the CIS arm as compared
to 635 (88% among ART-eligible participants) in the SOC arm initiated ART within the study
follow-up period (RR 1.16, 95% CI 0.96–1.40, p = 0.12) (Table 3). The median time from HIV
testing to ART initiation among eligible patients was 7.0 days (IQR 3.0–21.0) as compared to
14.0 days (IQR 7.0–13.0) in the CIS and SOC study arms, respectively (p< 0.001).
Retention in care, regardless of time to linkage or ART status, at 12 months was signifi-
cantly greater in participants in the CIS as compared to the SOC study arm, with an RR of 1.48
(95% CI 1.18–1.86, p = 0.002). Loss to follow-up during pre-ART care (RR = 0.60, 95% CI
0.40–0.89, p = 0.014) and after ART initiation (RR = 0.51, 95% CI 0.31–0.85, p = 0.013) was sig-
nificantly lower in the CIS arm as compared to the SOC arm.
For participants on ART for at least 6 months during follow-up regardless of retention sta-
tus, viral load data were available for 97% (N = 477/493) of participants in the CIS arm and
98% (N = 451/458) in the SOC arm. Viral suppression among participants on ART6 months
with available viral loads was similar by study arm at 88% in CIS and 90% in SOC (RR 0.97,
95% CI 0.88–1.07, p = 0.55).
There were 78 deaths (3.6% of the study population) that occurred during follow-up, and
this did not differ by study arm (35 deaths [3%] in the CIS study arm versus 43 deaths [4%] in
the SOC arm, with an RR of 0.80, 95% CI 0.46–1.35, p = 0.40) (Table 3). However, there was
nonsignificantly lower mortality among participants prior to ART initiation in the CIS arm
(10 deaths) compared to the SOC arm (23 deaths), with an RR of 0.44 (95% CI 0.19–1.01,
p = 0.05). Fig 3 compares the CIS study arm versus the SOC study arm across the HIV care
continuum from linkage to care within 1 month of testing through retention in care at 12
months after testing HIV positive.
In post hoc analyses, we examined achievement of the primary outcome between study
arms by key subgroups. The effect of the CIS, as compared to the SOC, was consistent across
all prespecified subgroups, including by age, sex, income, employment, marital status, travel
Fig 3. HIV care continuum comparing the combination intervention strategy (CIS) study arm versus the
standard of care (SOC) study arm.
https://doi.org/10.1371/journal.pmed.1002420.g003
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away from home in the past year, travel time to clinic, past HIV testing history, household
members with HIV, and type of clinic (Fig 4, S1 Table).
Discussion
In this cluster-randomized study, a novel combination strategy, inclusive of 5 evidence-based
interventions, was 50% more effective than the SOC in enhancing linkage to care plus reten-
tion in care among HIV-positive individuals. The robustness of this outcome is supported by
the consistent findings in the per-protocol analysis, in sensitivity analyses, and across sub-
groups of participants. In addition, the combination strategy was associated with improve-
ments across multiple steps of the care continuum, with an increased proportion of
participants who were assessed for ART eligibility, decreased time to ART eligibility assess-
ment, decreased time to ART initiation, increased retention at 12 months after HIV testing
regardless of time to linkage and ART status, and decreased mortality among participants
prior to ART initiation. However, high rates of viral suppression were similar among ART
patients by study arm.
In our study, the effect noted on the primary outcome appeared to be largely driven by
enhanced retention rather than by the linkage-to-care component. This finding may be due to
the high proportion of participants in both study arms who linked to care within 1 month of
HIV testing in both arms of the study (87% in the SOC arm and 92% in the CIS arm), and
thus, our sample size was insufficient to show a difference between the arms. The high propor-
tion of participant linkage was likely influenced by a national campaign to improve linkage
that was implemented during the study period [21].
The combination strategy significantly reduced loss to follow-up among participants
regardless of whether they were in pre-ART care or on treatment. Loss to follow-up, in both
Fig 4. Primary outcome by subgroups of participants. USD, US dollars; yrs, years.
https://doi.org/10.1371/journal.pmed.1002420.g004
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study arms, was higher among pre-ART participants, as compared to participants who had ini-
tiated ART. This is consistent with findings from other studies, including those from a large
study of 390,603 HIV-positive adults in Kenya, Mozambique, Rwanda, and Tanzania, in which
34.8% of all patients who had not initiated ART were lost from care at 12 months, compared to
5.8% among patients on ART [6]. While the pre-ART care phase should largely be minimized
with the release of the recent WHO guidelines that recommend offering ART to all HIV-posi-
tive individuals irrespective of CD4+ count or WHO disease stage, evidence suggests that
retention in care and on ART remains a challenge even in the context of “treatment for all”
[48]. For example, while adoption of Option B+, which entails initiation of ART for all HIV-
positive pregnant women, has been associated with an increase in the number of pregnant
women on ART, loss to follow-up has remained a challenge. Among 21,939 HIV-infected
pregnant women who started ART as per Option B+ in Malawi, 17% were lost to follow-up at
6 months after treatment start, with a 5-fold higher loss to follow-up compared to those who
initiated ART at a more advanced stage of HIV disease [49]. Thus, the findings from our study
remain relevant even though the study was conducted at a time when a CD4+ count threshold
was recommended for ART initiation.
In this study, viral suppression was high among all participants on ART for a minimum of
6 months, irrespective of study arm. This confirms the potency of the first-line regimen, con-
sisting of tenofovir, lamivudine, and efavirenz or nevirapine, and suggests that participants
were highly adherent to their medications. These findings build upon those from the Popula-
tion-based HIV Impact Assessment Project surveys that were conducted recently in Malawi,
Zambia, Zimbabwe, and Swaziland, which included nationally representative samples of indi-
viduals in which 87% of HIV-positive adults who reported being on ART were virally sup-
pressed (HIV-1 RNA < 1,000 copies/ml) [50,51]. Findings from this project survey in
Swaziland showed that among adults who were aware of their HIV-positive status and who
indicated being on ART, 92% had a suppressed viral load [52]. The finding of similarly high
proportions of viral suppression among participants in both arms of our study suggests that
the sample size was insufficient to detect a difference. In addition, it is important to note that
the interventions used in this study were not designed with a focus specifically on enhancing
medication adherence and viral suppression. Design of future combination strategies may pri-
oritize the use of interventions that focus specifically on enhancing adherence to ART, such as
the use of financial incentives to improve viral suppression [53].
Every effort was made to ascertain accurate loss to follow-up and mortality outcomes in our
study. It should be noted that reporting of accurate loss to follow-up and mortality outcomes
by HIV programs has been a controversial topic. This is due to the fact that when tracing was
done for individuals reported as lost to follow-up by HIV programs, a substantial proportion
were found to have either died or transferred care to another health facility [54]. We feel confi-
dent that it is unlikely that such misclassification occurred in our study as home tracing was
conducted for all study participants to ascertain their outcomes at the end of the 12-month fol-
low-up period. While the study was not powered to detect a difference between the study arms
in terms of mortality, the combination strategy appeared to have a meaningful—albeit not sta-
tistically significant—effect, with as much as 50% lower mortality noted among pre-ART
patients. This may be due to better retention in care among participants in the intervention
arm. Poor retention in care has been demonstrated to be associated with increased mortality,
likely due to missed clinic visits that deprive patients of clinical and laboratory assessments for
diagnosis of early complications and delay prompt initiation of ART [55].
We observed substantial heterogeneity in the primary outcome across clinics in both the
CIS and SOC study arms. This may reflect clinic-level differences such as clinic size and loca-
tion. For example, the CIS study unit with the lowest achievement of the study’s primary
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outcome was the largest clinic in urban Swaziland. It is possible that individuals who test HIV
positive at such a large clinic may seek ongoing care at clinics closer to their homes. Other rea-
sons could be differences in patient-level factors, such as sex, age, and immunological status,
which warrant further analyses.
To date, most intervention studies to address gaps in the HIV care continuum have focused
on 1 step in the continuum, largely that of ART initiation. The Rapid Initiation of Treatment
trial showed that single-visit ART initiation that included POC CD4+ count testing was associ-
ated with significantly higher ART initiation (97%) compared to the standard of care (72%)
[56]. The START-ART trial was a stepped-wedge cluster-randomized trial of 20 clinics in
Uganda that evaluated an intervention aimed at improving ART initiation among eligible
patients; this intervention was associated with a higher proportion of patients initiating ART
(80%) within 14 days after determination of ART eligibility compared to 38% in the control
group [13]. Finally, the Same Day ART Initiation Study in Haiti, which evaluated the effect of
same-day ART initiation on the day of HIV diagnosis among asymptomatic HIV-positive
adults with CD4+ count 500 cells/uL and WHO stage I or II disease, noted that a higher pro-
portion (53%) of participants randomized to same-day ART initiation were retained in care at
12 months with viral suppression compared to those in the standard of care arm (44%) [14].
Our study had several strengths, including the use of a pragmatic approach consistent with
implementation science design. Specifically, it utilized broad eligibility criteria, was conducted
within established health facilities, tested feasible interventions that were delivered primarily
by available staff rather than research staff, and assessed the primary outcome largely through
routinely available data. In addition, the study included the majority of clinics in Swaziland
and involved cluster-randomized design rather than randomization of individual participants,
which allowed for ease of implementation and avoided disruption of services within the clinics.
The study also uniquely assessed the effect of the delivery of multiple interventions packaged
in 1 strategy aimed at multiple steps in the HIV care continuum. Thus, implementation of the
study strategy has the potential to achieve not only prompt ART initiation but also better
retention in care and on ART, consequently enhancing individual and society benefits from
the “treat all” approach.
The primary limitations of this study included a limited number of clusters, although it was
inclusive of all the available clusters in the country. At the time of study initiation, there were
only 11 secondary health facilities offering HIV services in Swaziland, and we selected 10 of
these for participation in this study. Consequently, it is possible that the cluster randomization
did not evenly distribute all determinants of linkage and retention other than the study inter-
ventions between treatment arms. While it is encouraging that analyses adjusting for individ-
ual-level differences between treatment arms did not appreciably change the results, we cannot
definitively rule out residual confounding as a potential explanation of the findings. In addi-
tion, the design focused on evaluation of a package of interventions as 1 strategy and, thus, it
did not allow for evaluation of the effectiveness of individual components of the combination
approach. Another limitation was use of self-reported linkage and retention at other clinics to
ascertain undocumented transfers to other clinics outside of the study unit.
Conclusions
The Link4Health study demonstrated that a combination strategy of evidence-based interven-
tions, aimed at gaps in various steps of the HIV care continuum, was highly effective in
enhancing linkage of HIV-positive individuals to care plus increasing their retention in care
and on ART. The study also showed that once participants initiated ART, viral load suppres-
sion was high irrespective of the study arm. Cost effectiveness and qualitative analyses are
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ongoing in order to inform decision makers considering adoption of this strategy. Our find-
ings offer an effective strategy that can advance the quality of HIV programs in Swaziland and
that can be adapted to other similar contexts.
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